Literature DB >> 1333875

Regulation of ornithine decarboxylase by parathyroid hormone in osteoblastic cell systems.

S L Cheng1, A Fausto, O A Jänne, L V Avioli.   

Abstract

Parathyroid hormone (PTH) has been shown to induce osteoblastic activity via a complex signal transduction process which is mediated either by cAMP or cytosolic calcium ([Ca2+]i), or a combination thereof. One of the PTH functions in osteoblasts is the induction of ornithine decarboxylase (ODC) activity. We have analyzed the second messengers involved in this process. 8-Bromo cAMP, a cAMP derivative, enhanced ODC activity in UMR106-01 osteoblastic cell system. The calcium ionophore A23187 and the protein kinase stimulator phorbol-12-myristate 13-acetate did not alter ODC activity. ODC activity was increased by bPTH-(1-34), PGE1, and PGE2 which stimulated both cAMP and [Ca2+]i. In contrast, PTH-(2-34), propionyl bPTH-(2-34), bPTH-(3-34), bPTH-(7-34), and PGF2 alpha, which only enhanced [Ca2+]i but not cAMP, had no effect on ODC activity. Thus, the stimulation of ODC in UMR106 cells by PTH appeared to be mediated primarily via the cAMP signal transduction pathway, and the mere increase in intracellular calcium could not account for the stimulation of ODC activity. ODC mRNA level was found to be increased by PTH treatment. Therefore, translation of ODC may be stimulated by PTH. Moreover, PTH also stimulated ODC antizyme activity, suggesting that the ODC degradation rate was increased.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333875     DOI: 10.1007/bf00316882

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  41 in total

1.  Effects of lipopolysaccharides and prostaglandins on rat bone cell calcium and cyclic AMP.

Authors:  R Dziak; E Hausmann; Y W Chang
Journal:  Arch Oral Biol       Date:  1979       Impact factor: 2.633

2.  Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.

Authors:  M Gunness-Hey; J M Hock
Journal:  Metab Bone Dis Relat Res       Date:  1984

3.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

4.  The effect of calcium and 3',5' cAMP on the induction of ornithine decarboxylase activity in bone and bone cells.

Authors:  P M Boonekamp
Journal:  Bone       Date:  1985       Impact factor: 4.398

5.  Parathyroid hormone stimulates the proliferation of cells derived from human bone.

Authors:  B R MacDonald; J A Gallagher; R G Russell
Journal:  Endocrinology       Date:  1986-06       Impact factor: 4.736

6.  Effects of long-term daily administration of prostaglandin-E2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats.

Authors:  H Z Ke; W S Jee; S Mori; X J Li; D B Kimmel
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

7.  Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells.

Authors:  R Civitelli; K A Hruska; J J Jeffrey; A J Kahn; L V Avioli; N C Partridge
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

Review 8.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

9.  Parathyroid hormone-activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. cAMP-dependent and cAMP-independent calcium channels.

Authors:  D T Yamaguchi; T J Hahn; A Iida-Klein; C R Kleeman; S Muallem
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

10.  Accumulation of ornithine decarboxylase-antizyme complex in HMOA cells.

Authors:  Y Murakami; K Fujita; T Kameji; S Hayashi
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.